BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Methylcholanthrene

A carcinogen that is often used in experimental cancer studies.

300+ PubMed studies analyzed · Evidence Score: 40.5

Research Domains

Methylcholanthrene has been studied across 16 research domains including 🔬 Oncology, 🫁 Liver & Detox, ✨ Skin & Hair, 🧬 Hormones, 🫘 Kidney. The primary research focus is 🔬 Oncology with 47% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Methylcholanthrene, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Propanil
10 shared targets
fluoranthene
9 shared targets
2-Acetylaminofluorene
13 shared targets
Secologanin
11 shared targets
Phenelzine
14 shared targets
Linuron
9 shared targets
Piperonyl
12 shared targets
Phenylthiourea
10 shared targets
thiophanate
9 shared targets
Stanozolol
11 shared targets
Loading evidence profile...

This evidence profile for Methylcholanthrene is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.